quinoxalines has been researched along with Leukemia, Myeloid, Acute in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bonnet, PA; Deleuze-Masquefa, C; El Hajj, H; El Hajj, R; El Sabban, M; Hamie, M; Hleihel, R; Jishi, B; Skayneh, H | 1 |
Chen, X; Chen, Y; Fan, Y; Li, D; Luo, Y; Wang, T; Wu, L; Xu, J; Zhang, L; Zhuang, Y | 1 |
Bosman, MC; Quax, WJ; Schuringa, JJ; Vellenga, E | 1 |
Bensinger, D; Göring, S; Naumann, EC; Schmidt, B | 1 |
Bastie, JN; Delva, L; Nguyen, CH; Quéré, R; Saint-Paul, L | 1 |
Berthier, CP; Bonnet, PA; Deleuze-Masquefa, C; El Hajj, HA; Hamie, MH; Hleihel, RS; Karam, MM; Nabbouh, AI; Saliba, JL; Tawil, NM; Wu, HJM | 1 |
Bruserud, Ø; Ersvaer, E; Hatfield, KJ; Kittang, AO; Lassalle, P; Reikvam, H | 1 |
Cool, RH; Knapper, S; Natoni, A; O'Dwyer, M; O'Reilly, A; Quax, WJ; Reeve, J; Reis, CR; Samali, A; Serrano, L; Szegezdi, E; van der Sloot, AM | 1 |
8 other study(ies) available for quinoxalines and Leukemia, Myeloid, Acute
Article | Year |
---|---|
EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Topics: Animals; Cysteine Endopeptidases; Humans; Leukemia, Myeloid, Acute; Mice; Mutation; Nuclear Proteins; Nucleophosmin; Quinoxalines; Sumoylation | 2022 |
NF-κB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells.
Topics: Animals; DNA Damage; DNA Repair; Feedback, Physiological; Gene Knockdown Techniques; Heterografts; Humans; Imidazoles; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Promoter Regions, Genetic; Quinoxalines; Transcription Factor RelA | 2019 |
Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
Topics: Antigens, CD34; Boronic Acids; Bortezomib; Coculture Techniques; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Humans; I-kappa B Kinase; Imidazoles; Leukemia, Myeloid, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neoplastic Stem Cells; NF-kappa B; Primary Cell Culture; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Quinoxalines; Recombinant Proteins; RNA, Small Interfering; Stromal Cells; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2013 |
Computer-guided design, synthesis, and biological evaluation of quinoxalinebisarylureas as FLT3 inhibitors.
Topics: Animals; Drug Design; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Protein Kinase Inhibitors; Quinoxalines; Zebrafish | 2015 |
[CD45 phosphatase, a relevant target for the treatment of acute myeloid leukemia].
Topics: Antineoplastic Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Molecular Targeted Therapy; Quinoxalines; Signal Transduction | 2016 |
Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleolus; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cytoplasm; Flow Cytometry; Humans; Immunoblotting; Leukemia, Myeloid, Acute; Mice; Microscopy, Confocal; Mutant Proteins; Mutation; Nuclear Proteins; Nucleophosmin; Phosphorylation; Poly(ADP-ribose) Polymerases; Quinoxalines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |
Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release.
Topics: Adult; Aged; Aged, 80 and over; Angiopoietin-1; Angiopoietin-2; Antibodies; Boronic Acids; Bortezomib; Cell Proliferation; Cells, Cultured; Coculture Techniques; Endothelial Cells; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Imidazoles; Interleukin-8; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Osteoblasts; Proteoglycans; Pyrazines; Quinoxalines; Receptor Cross-Talk; Receptor, TIE-2; Signal Transduction | 2010 |
Targeting AML through DR4 with a novel variant of rhTRAIL.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Epidermal Cells; Female; Humans; Imidazoles; Keratinocytes; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Membrane Potentials; Middle Aged; Quinoxalines; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2011 |